Suppr超能文献

在2型糖尿病患者和健康受试者中,肝素后血浆脂蛋白脂肪酶而非肝脂肪酶活性与血浆脂联素相关。

Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.

作者信息

De Vries Rindert, Wolffenbuttel Bruce H R, Sluiter Wim J, van Tol Arie, Dullaart Robin P F

机构信息

Department of Endocrinology, Groningen University Medical Center, Groningen, The Netherlands.

出版信息

Clin Lab. 2005;51(7-8):403-9.

Abstract

The aim of this study was to determine the relationships of plasma adiponectin with post-heparin plasma lipoprotein lipase (LPL) and hepatic lipase (HL) activities, and to evaluate whether plasma adiponectin contributes to diabetes-associated dyslipidaemia. Plasma adiponectin, post-heparin plasma lipase activities, lipoproteins and insulin sensitivity (hyperinsulinaemic euglycaemic clamp) were measured in 24 male type 2 diabetic patients and 24 age-matched healthy men. Plasma triglycerides (P < 0.01) and apolipoprotein B levels (P < 0.01) were higher, and HDL cholesterol was lower (P < 0.05) in type 2 diabetic patients. Plasma adiponectin, as well as LPL and HL activities were not significantly different between diabetic and healthy subjects. Multiple regression analysis showed that LPL activity was positively related with plasma adiponectin (P < 0.05). In contrast, HL activity was positively related with body mass index (P < 0.02) and waist/hip ratio (P < 0.05, multiple r = 0.74), but not with plasma adiponectin. Plasma adiponectin was positively associated with insulin sensitivity (P = 0.001), age (P < 0.02) and LPL activity (P < 0.05, multiple r = 0.64), but not with the presence of diabetes and HL activity. Plasma triglycerides were negatively related with LPL activity (P = 0.002) and positively with the diabetic state (P = 0.001, multiple r = 0.58). HDL cholesterol was positively related with plasma adiponectin (P = 0.003) and negatively with HL activity (P < 0.02) as well as with the presence of diabetes (P = 0.05, multiple r = 0.59). We conclude that post-heparin plasma LPL activity, but not HL activity, is related with plasma adiponectin. Plasma adiponectin appears to be a determinant of plasma triglycerides via an effect on LPL activity. It seems unlikely that plasma adiponectin predicts the effects of the diabetic state as such on high plasma triglycerides and low HDL cholesterol.

摘要

本研究的目的是确定血浆脂联素与肝素后血浆脂蛋白脂肪酶(LPL)及肝脂肪酶(HL)活性之间的关系,并评估血浆脂联素是否与糖尿病相关的血脂异常有关。对24名男性2型糖尿病患者和24名年龄匹配的健康男性测量了血浆脂联素、肝素后血浆脂肪酶活性、脂蛋白及胰岛素敏感性(高胰岛素正常血糖钳夹法)。2型糖尿病患者的血浆甘油三酯(P < 0.01)和载脂蛋白B水平(P < 0.01)较高,而高密度脂蛋白胆固醇较低(P < 0.05)。糖尿病患者与健康受试者之间的血浆脂联素以及LPL和HL活性无显著差异。多元回归分析显示,LPL活性与血浆脂联素呈正相关(P < 0.05)。相反,HL活性与体重指数呈正相关(P < 0.02),与腰臀比呈正相关(P < 0.05,复相关系数r = 0.74),但与血浆脂联素无关。血浆脂联素与胰岛素敏感性呈正相关(P = 0.001)、与年龄呈正相关(P < 0.02)、与LPL活性呈正相关(P < 0.05,复相关系数r = 0.64),但与糖尿病的存在及HL活性无关。血浆甘油三酯与LPL活性呈负相关(P = 0.002),与糖尿病状态呈正相关(P = 0.001,复相关系数r = 0.58)。高密度脂蛋白胆固醇与血浆脂联素呈正相关(P = 0.003),与HL活性呈负相关(P < 0.02),也与糖尿病的存在呈负相关(P = 0.05,复相关系数r = 0.59)。我们得出结论,肝素后血浆LPL活性而非HL活性与血浆脂联素有关。血浆脂联素似乎通过对LPL活性的影响而成为血浆甘油三酯的一个决定因素。血浆脂联素似乎不太可能预测糖尿病状态本身对高血浆甘油三酯和低高密度脂蛋白胆固醇的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验